Cargando…
Attenuation of ischemia–reperfusion injury by intracoronary chelating agent administration
Ischemia–reperfusion (IR) injury accelerates myocardial injury sustained during the myocardial ischemic period and thus abrogates the benefit of reperfusion therapy in patients with acute myocardial infarction. We investigated the efficacy of intracoronary ethylenediaminetetraacetic acid (EDTA) admi...
Autores principales: | Han, Donghoon, Kang, Si-Hyuck, Yoon, Chang-Hwan, Youn, Tae-Jin, Chae, In-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825805/ https://www.ncbi.nlm.nih.gov/pubmed/35136090 http://dx.doi.org/10.1038/s41598-022-05479-2 |
Ejemplares similares
-
Author Correction: Attenuation of ischemia–reperfusion injury by intracoronary chelating agent administration
por: Han, Donghoon, et al.
Publicado: (2023) -
Attenuating ischemia/reperfusion injury in rat cardiac transplantation by intracoronary infusion with siRNA cocktail solution
por: Yang, Bo, et al.
Publicado: (2020) -
Intracoronary Delivery of Mitochondria to Prevent Ischemia–Reperfusion Injury: Challenging Pathway From Bench to Bedside
por: Aimo, Alberto, et al.
Publicado: (2020) -
Intracoronary Administration of Microencapsulated HGF in a Reperfused Myocardial Infarction Swine Model
por: Blanco-Blázquez, Virginia, et al.
Publicado: (2023) -
Risperidone Administration Attenuates Renal Ischemia and Reperfusion Injury following Cardiac Arrest by Antiinflammatory Effects in Rats
por: Kim, Yang Hee, et al.
Publicado: (2023)